Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G. P. Prevost"'
Publikováno v:
Anti-cancer agents in medicinal chemistry. 8(8)
The identification of a CDC25 inhibitor to arrest the cell cycle closely followed the discovery of CDC25 by Russell and Nurse in 1986. Recent advances at the preclinical and clinical stages reinforce the rationale to consider CDC25 as a relevant targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3a1a9e747770f9886b3c4807080352
https://pubmed.ncbi.nlm.nih.gov/19075568
https://pubmed.ncbi.nlm.nih.gov/19075568
Autor:
G P, Prevost, A, Pradines, M C, Brezak, M O, Lonchampt, I, Viossat, I, Ader, C, Toulas, P, Kasprzyk, T, Gordon, G, Favre, B, Morgan
Publikováno v:
International journal of cancer. 91(5)
Oncogenic mutations of the ras gene leading to constitutive activation of downstream effectors have been detected in a wide spectrum of human cancers (pancreas, thyroid, colon, non-small-cell lung cancer). Membrane anchorage of Ras, required for func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22ec5b0a2ee344292b5dd933a2eda282
https://pubmed.ncbi.nlm.nih.gov/11267986
https://pubmed.ncbi.nlm.nih.gov/11267986
Autor:
G P, Prevost, A, Pradines, I, Viossat, M C, Brezak, K, Miquel, M O, Lonchampt, P, Kasprzyk, G, Favre, B, Pignol, C, Le Breton, J, Dong, B, Morgan
Publikováno v:
International journal of cancer. 83(2)
Oncogenic mutations of the ras gene leading to constitutive activation of downstream effectors have been detected in a large spectrum of human cancers (pancreas, thyroid, colon and NSCLC). Membrane anchorage of Ras required for functional activity in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3205bb3645695f5cfd92992cce1b3fe4
https://pubmed.ncbi.nlm.nih.gov/10471540
https://pubmed.ncbi.nlm.nih.gov/10471540
Autor:
G. P. Prevost, Zina Koob, A. Perez, Tauhid Ali, E. Bascompta, Barry V. L. Potter, M. Hillairet de Boisferon, Michael F. Reed, Francis Bichat
Publikováno v:
European Journal of Cancer Supplements. 6:52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a8f7df9f45da7466210fd62b8f3ce84
https://doi.org/10.1016/s1359-6349(08)72095-0
https://doi.org/10.1016/s1359-6349(08)72095-0
Autor:
Tauhid Ali, E. Bascompta, M. Hillairet de Boisferon, A. Perez, G. P. Prevost, Michael F. Reed, Zina Koob, Barry V. L. Potter, Atul Purohit, Francis Bichat, L. W. Lawrence Woo
Publikováno v:
Journal of Clinical Oncology. 26:14683-14683
14683 Background: Steroid sulfatase (STS) is a new target for the treatment of steroid hormone-dependent diseases such as breast, prostate or endometrial cancer. In breast cancer, estrogens play a ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::113707120c3656561974ed896091b1b5
https://doi.org/10.1200/jco.2008.26.15_suppl.14683
https://doi.org/10.1200/jco.2008.26.15_suppl.14683